Allergen Extract Mixer Training Program 2019

November 8, 2019

This inaugural program will offer didactic presentations, developed specifically to detail the expectations of the revised USP 797, followed by a hands-on workshop, where attendees will accurately garb to meet 797 standards, participate in area sterilization techniques and perform individualized media fill and glove tip testing. The session will conclude with a brief exam, and certificates of completion will be awarded to those who successfully complete the training program.


The live activity was supported by an independent educational grant from the following commercial supporter:

  • Stallergenes Greer

Target Audience

  • All practicing allergists/immunologists
  • Fellows in allergy/immunology training programs
  • Primary care physicians who care for allergy patients
  • Allied health professionals in the field of allergy and immunology 

Learning Objectives

At the conclusion of this activity, participants should be able to:

  • Understand the requirements for a USP 797-compliant mixing station.
  • Provide sterile, safe immunotherapy kits for patients.
  • Ensure allergy kits contain appropriate allergen extracts in the appropriate quantities for safe immunotherapy administration, mixed according to a patient’s individualized prescription.
Additional information

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all relevant financial relationships with any commercial interest that have occurred within the past 12 months. All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure be provided to the learners prior to the start of the activity. Individuals with no relevant financial relationships must also inform the learners that no relevant financial relationships exist. Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials. Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI.

All identified conflicts of interest have been resolved.


Course summary
Available credit: 
  • 6.50 AMA PRA Category 1 Credit™
  • 6.50 Attendance
  • 6.50 CBRN
Course opens: 
Course expires: 
Event starts: 
11/08/2019 - 8:00am CST
Event ends: 
11/08/2019 - 4:30pm CST
George R. Brown Convention Center
Houston, TX
United States

All identified conflicts of interest have been resolved.

Education Staff/Committee/Reviewers have no relevant financial relationships to disclose, except as may be listed above.



Available Credit

  • 6.50 AMA PRA Category 1 Credit™
  • 6.50 Attendance
  • 6.50 CBRN
Please login or create an account to take this course.